| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.009 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |